Company Information
 
 
  Stock Code 
 
和黃醫藥(中國)有限公司 Code:  00013
HUTCHMED (CHINA) LIMITED Website: http://www.hutch-med.com
Income Statement
  2025/12
USD($)
Change 2024/12
USD($)
2023/12
USD($)
Turnover548,512,000-12.962%630,201,000837,999,000
Operating Profit / (Loss)498,691,000--(1,107,000)58,308,000
Exceptional Items--------
Profit / (Loss) of Associated Co. & Jointly Controlled Entity--------
Profit / (Loss) before Taxation498,691,000--(1,107,000)58,308,000
Taxation(63,610,000)--(7,192,000)(4,509,000)
Minority Interests(823,000)--(441,000)(314,000)
Profit / (Loss) Attributable to Shareholders456,909,0001,111.029%37,729,000100,780,000
 
Net Interest Income / (Expense)47,012,00026.349%37,208,00035,386,000
Depreciation & Amortization13,308,0007.836%12,341,0008,207,000
Directors Remuneration7,612,0007.910%7,054,0006,451,000
 
EPS / (LPS) (cts)53.0001,225.000%4.00012.000
DPS (cts)0.000--0.0000.000
 
Dividend Payout Ratio (%)0.000%--0.000%0.000%
NBV Per Share ($)1.41962.765%0.8720.838
Financial Ratio
  2025/12
USD($)
Change 2024/12
USD($)
2023/12
USD($)
Operating Margin (%)90.917%--(0.176)%6.958%
Interest Coverage Ratio (x)175.063--0.61577.822
ROAA (%)30.186%--2.955%8.728%
ROAE (%)45.740%--5.063%15.032%
 
Copyright ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.